Can-Fite BioPharma Ltd.
(NYSE Amex Equities : CANF)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
AMGNAmgen, Inc. -3.40%239.301.3%$815.48m
MRNAModerna, Inc. -3.95%67.110.0%$733.13m
NVAXNovavax, Inc. 1.34%109.8196.5%$703.24m
IMMUImmunomedics, Inc. 0.02%85.5511.0%$601.11m
GILDGilead Sciences, Inc. -2.21%63.611.0%$585.88m
REGNRegeneron Pharmaceuticals, Inc. -1.30%548.022.7%$439.31m
VRTXVertex Pharmaceuticals, Inc. -1.64%261.051.9%$323.79m
BIIBBiogen, Inc. -3.04%266.151.6%$322.86m
ILMNIllumina, Inc. -6.92%275.063.5%$291.44m
SRNESorrento Therapeutics, Inc. -1.59%9.281.5%$270.45m
ALXNAlexion Pharmaceuticals, Inc. -2.80%110.542.0%$259.09m
MNTAMomenta Pharmaceuticals, Inc. 0.16%52.353.0%$237.75m
BMRNBioMarin Pharmaceutical, Inc. -2.78%77.174.3%$232.82m
VXRTVaxart, Inc. 7.18%8.810.0%$228.90m
SGENSeattle Genetics, Inc. -1.70%177.876.0%$190.86m

Company Profile

Can-Fite BioPharma Ltd. engages in the development of drugs for cancer and inflammatory diseases. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.